Volume 13, Number 1—January 2007
Dispatch
Ophthalmic Surgery in Prion Diseases
Table 2
Characteristic | Ophthalmic surgery |
Total | p value | |
---|---|---|---|---|
No, n = 458 | Yes, n = 10 | |||
Female/male | 263/195 | 6/4 | 269/199 | 0.57 |
Age at onset, y; mean ± SD | 66.8 ± 9.9 | 68.3 ± 9.1 | 66.8 ± 9.9 | 0.74 |
Disease duration,† mean ± SD | 4.2 ± 4.8 | 9.1 ± 6.0 | 4.3 ± 4.9 | 0.0004 |
Clinical symptoms (%) | ||||
Dementia (+)/visual impairment (+) | 153 (34.2) | 4 (40.0) | 157 (34.3) | |
Dementia (+)/visual impairment (–) | 239 (53.3) | 3 (30.0) | 242 (52.8) | 0.0004 |
Dementia (–)/visual impairment (+) | 16 (3.6) | 3 (30.0) | 19 (4.1) | |
Dementia (–)/visual impairment (–) | 40 (8.9) | 0 | 40 (8.7) |
*sCJD, sporadic Creutzfeldt-Jakob disease; SD, standard deviation; +, with; –, without.
†Disease duration, the duration from onset to akinetic mutism or death if patients never displayed akinetic mutism.
1Current affiliation: Ishikawa Prefecture Central Hospital, Kanazawa, Japan
2Member, Creutzfeldt-Jakob Disease Surveillance Committee, Japan
Page created: June 28, 2010
Page updated: June 28, 2010
Page reviewed: June 28, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.